Interacting Drugs |
Repaglinide and metformin vs CYP2C8 Inhibitors (Strong) |
Security Level |
 |
Mechanism |
CYP2C8 Inhibitors (Strong): May decrease the metabolism of CYP2C8 Substrates (High risk). |
Management |
Consider therapy modification |
Repaglinide and metformin vs CYP2C8 Inhibitors (Strong)
Post Review about Repaglinide and metformin vs CYP2C8 Inhibitors (Strong) Click here to cancel reply.
Other Interactions of Repaglinide and metformin
Other Interactions of CYP2C8 Inhibitors (Strong)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.